Latest raise
$80M
Date raised
October 1, 2026
Round
Series B
InvestorsAlta Partners
Websitekymathera.com
About Rob Kania
a provider of precision medicines for genetically defined diseases
- Who is Rob Kania?
- Rob Kania is listed as Chief Executive Officer at KymaThera, a biotechnology company based in San Diego, CA, United States.
- How much did KymaThera raise?
- KymaThera raised $80M in a Series B round on October 1, 2026 (32 days ago). Backed by Alta Partners.
Get newly funded founders every week
A free weekly list of startups that just raised.